A propensity score‐matched, real‐world comparison of ustekinumab vs vedolizumab as a second‐line treatment for Crohn’s disease. The Cross Pennine study II
Lenti, Marco Vincenzo, Dolby, Vivien, Clark, Tanya, Hall, Veronica, Tattersall, Suzanne, Fairhurst, Francesca, Kenneth, Catherine, Walker, Rachael, Kemp, Karen, Borg‐Bartolo, Simon, Limdi, Jimmy K., Taylor, Jo, Townsend, Tristan, Subramanian, Sree, Storey, Daniel, Assadsangabi, Arash, Stansfield, Catherine, Smith, Paul, Byrne, Debra, De Silvestri, Annalisa, Selinger, Christian P.
Published in Alimentary pharmacology & therapeutics (01.04.2022)
Published in Alimentary pharmacology & therapeutics (01.04.2022)
Get full text
Journal Article